Cargando…
Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model
Protein vaccines were prepared from the serotype antigen of group B Neisseria meningitidis strain M986. The detergents Triton X-100, Emulphogene BC-720, and deoxycholate were used to removed the toxic lipopolysaccharide (LPS) portion of the serotype antigen. The LPS was most preferentially solubiliz...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1978
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184206/ https://www.ncbi.nlm.nih.gov/pubmed/416164 |
Ejemplares similares
-
Protection against group B meningococcal disease. II. Infection and resulting immunity in a guinea pig model
Publicado: (1978) -
Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model
Publicado: (1976) -
A meningococcal B vaccine induces cross-protection against gonorrhea
por: Azze, Rolando Felipe Ochoa
Publicado: (2019) -
Use of a Guinea Pig-Specific Transcriptome Array for Evaluation of Protective Immunity against Genital Chlamydial Infection following Intranasal Vaccination in Guinea Pigs
por: Wali, Shradha, et al.
Publicado: (2014) -
CORTIN PROTECTION AGAINST ANAPHYLACTIC SHOCK IN GUINEA PIGS
por: Wolfram, J., et al.
Publicado: (1935)